Company profile for Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc

Suanfarma, at the Core of a Better Life.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

Contact Supplier

Moehs Group, a reference company in the production of pharmaceutical active ingredients.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-2-m-2025-11-03

Contact Supplier

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

38 News #PharmaBuzz

media
38 News #PharmaBuzz

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Titan is a specialty pharmaceuticals company that develops therapeutics for select chronic diseases utilizing its innovative, long-term, continuous drug delivery platform, ProNeura. The company's lead product is Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction. The U.S. Food and Drug Administration approved Probuphine on May 26, 2016. Probuphine is the first marketed product to pr...

Titan is a specialty pharmaceuticals company that develops therapeutics for select chronic diseases utilizing its innovative, long-term, continuous drug delivery platform, ProNeura. The company's lead product is Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction. The U.S. Food and Drug Administration approved Probuphine on May 26, 2016. Probuphine is the first marketed product to provide maintenance treatment of opioid addiction continuously for six months following a single administration procedure.

Tides AsiaTides Asia

Not Confirmed

Not Confirmed

24-26 February, 2026

Tokyo, Japan
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California
Biotech ShowcaseBiotech Showcase

Not Confirmed

Not Confirmed

12-14 January, 2026

San Diego, California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

400 Oyster Point Boulevard, Suite 505 South San Francisco, CA 94080-1958

Telephone

Telephone

650-244-4990

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.titanpharm.com/

Linkedin

https://in.linkedin.com/company/titan-pharmaceuticals

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Titan Pharmaceuticals Announces $600,000 Stock Placement

27 Jun 2025

// GLOBENEWSWIRE

Titan Files for Business Combo With TalenTec Sdn. Bhd.

03 Jun 2025

// GLOBENEWSWIRE

Titan Pharmaceuticals Announces $1M Private Placement

11 Apr 2025

// GLOBENEWSWIRE

Titan Pharma, Inc. Announces Receipt of Notice from Nasdaq

27 Nov 2024

// GLOBENEWSWIRE

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

19 Aug 2024

// GLOBENEWSWIRE

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

25 Jan 2024

// GLOBENEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search